Our Focus: The Patient
Patients are at the center of all our work at Sandoz. Each day, we strive to find new, innovative ways of delivering affordable, high-quality healthcare solutions to patients who need them. We already provide a broad portfolio of standard generic medicines and are leading the way in the development and production of differentiated generics that make a real difference in patient healthcare. These generics contain the same active substances as reference medicines and are as effective as the brand name versions, all at an affordable price.
Sandoz is dedicated to developing, producing and delivering high-quality medicines. As a Novartis company, we adhere to rigorous international quality standards, which ensure that our customers can trust us to deliver safe and effective medicines. With a world-wide network of state-of-the-art development facilities and modern production plants, Sandoz leads the way within the generics industry, setting new industry standards through constant innovation.
By providing a wide portfolio of high-quality generics in over 140 countries, we make important medicines available to more than 90% of the world population. Our global reach not only ensures world-wide access to high-quality medicines and treatments, but also helps decrease the burden of illness by providing them at a fraction of the cost. Sandoz is committed to ensuring that affordable healthcare is always within every patient’s reach.
Sandoz is dedicated to meeting patient needs through constant innovation. With over 10 major development centers across the globe, we boast one of the richest industry pipelines with about 800 compounds in development. Leading the way in differentiated generics, we are also the pioneer and global leader in the newly emerging field of biosimilars, new versions of biopharmaceuticals following the loss of patent protection. Our expertise and know-how in the development and production of such complex products, ranges across a variety of technologies from biosimilars, injectables and respiratory inhalables to transdermal patches, implants and complex oral solids.